Abstract
Randomized comparison between KTd and KRd induction followed by second randomization to carfilzomib in transplant-ineligable patients with newly diagnosed multiple myeloma.
© 2024 Wiley Periodicals LLC.
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Dexamethasone / therapeutic use
-
Humans
-
Induction Chemotherapy
-
Lenalidomide / therapeutic use
-
Multiple Myeloma* / diagnosis
-
Multiple Myeloma* / drug therapy
Substances
-
Dexamethasone
-
Lenalidomide